Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Systemic Lupus Erythematosus
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Acute Tracheal Necrosis after Intubation with Childhood Onset Systemic Lupus Erythematosus
Journal:
Chest
Treatment Used:
High-Dose Steroid Therapy
Number of Patients:
1
Published —
February 10, 2021
This case report describes a childhood onset systemic lupus erythematosus patient with acute tracheal necrosis that she developed after intubation.
Condition:
Systemic Lupus Erythematosus
Journal:
BioMed research international
Treatment Used:
Mycophenolate Mofetil
Number of Patients:
119
Published —
February 10, 2021
In this study, researchers evaluated the safety and effectiveness of mycophenolate mofetil for the treatment of systemic lupus erythematosus in Japanese patients.
Condition:
Refractory Noninfectious Uveitis
Journal:
Yonsei medical journal
Treatment Used:
Adalimumab
Number of Patients:
14
Published —
February 02, 2021
This study tested the safety and efficacy of using adalimumab to treat patients with refractory noninfectious uveitis.
Condition:
Isolated Libman-Sacks Endocarditis with Primary Antiphospholipid Syndrome
Journal:
International heart journal
Treatment Used:
Mitral Valve Repair
Number of Patients:
1
Published —
February 01, 2021
This case report describes a patient with isolated Libman-Sacks endocarditis and primary antiphospholipid syndrome.
Condition:
Patients with Rheumatic Diseases and COVID-19
Journal:
RMD open
Treatment Used:
Immunosuppression
Number of Patients:
334
Published —
January 29, 2021
This study evaluated risk factors associated with unfavorable outcomes in patients with immune-mediated rheumatic disease (IMRD) and COVID-19.
Condition:
Ulcerative Colitis
Journal:
Middle East African journal of ophthalmology
Treatment Used:
Adalimumab
Number of Patients:
1
Published —
January 25, 2021
The study researched the outcomes of Adalimumab in patients with ulcerative colitis.
Condition:
Severe Interstitial Pneumonia
Journal:
BMC pulmonary medicine
Treatment Used:
Aggressive Immunosuppressive Regimen and Extracorporeal Blood Purification with Rapid Reduction of Circulating Autoantibodies
Number of Patients:
3
Published —
January 07, 2021
The study researched the outcomes of rapid reduction of circulating autoantibodies for treating severe interstitial pneumonia.
Condition:
Shrinking Lung Syndrome in Pediatric Systemic Lupus Erythematosus
Journal:
Pediatric rheumatology online journal
Treatment Used:
Rituximab
Number of Patients:
1
Published —
January 07, 2021
The study researched the outcomes of using rituximab to treat shrinking lung syndrome in pediatric systemic lupus erythematosus.
Condition:
Lupus Membranous Nephropathy
Journal:
RMD open
Treatment Used:
Filgotinib and Lanraplenib
Number of Patients:
9
Published —
December 31, 2020
In this study, researchers evaluated the safety and effectiveness of filgotinib and lanraplenib for the treatment of lupus membranous nephropathy.
Condition:
Systemic Lupus Erythematosus with Chylothorax and/or Chylous Ascites
Journal:
Medicine
Treatment Used:
Glucocorticoids, Immunosuppressants, and Surgery
Number of Patients:
15
Published —
December 29, 2020
The study researched treatment for systemic lupus erythematosus with chylothorax and/or chylous ascites.
Condition:
Subacute Progressive Interstitial Lung Disease (ILD) Associated with Systemic Lupus Erythematosus (SLE)
Journal:
Modern rheumatology case reports
Treatment Used:
Mycophenolate Mofetil
Number of Patients:
1
Published —
December 03, 2020
This case report describes a patient diagnosed with subacute progressive interstitial lung disease (ILD) associated with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.
Condition:
Immune-Mediated Inflammatory Diseases
Journal:
RMD open
Treatment Used:
Janus Kinase Inhibitors (JAKi)
Number of Patients:
0
Published —
November 14, 2020
This review of the literature examined the safety and effectiveness of Janus kinase (JAK) inhibition in patients with immune-mediated inflammatory diseases (IMIDs).
Showing 1-12 of 166
Next